AVROBIO, Inc. (28)

Browse by Contract Category

Contracts

Amended and Restated Master Services Agreement, by and between the Registrant and Miltenyi Biotec, Inc., dated November 20, 2021 (Filed With SEC on August 9, 2022)
Second Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on June 10, 2022)
Loan and Security Agreement, dated November 2, 2021, by and among the Registrant, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and... (Filed With SEC on November 4, 2021)
2020 Inducement Plan and form of award agreement thereunder (Filed With SEC on March 18, 2021)
Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020 (Filed With SEC on March 16, 2020)
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2022)
Employment Agreement, by and between the Registrant and Essra Ridha, dated October 6, 2021 (Filed With SEC on March 17, 2022)
Amendment to Employment Agreement, by and between the Registrant and Deanna Petersen, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Amendment to Employment Agreement, by and between the Registrant and Chris Mason, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Amendment to Employment Agreement, by and between the Registrant and Diana Escolar, MD, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Amendment to Employment Agreement, by and between the Registrant and Steven Avruch, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Amendment to Employment Agreement, by and between the Registrant and Erik Ostrowski, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Amendment to Employment Agreement, by and between the Registrant and Geoff MacKay, dated April 5, 2021 (Filed With SEC on May 13, 2021)
Employment Agreement, by and between the Registrant and Diana Escolar, dated December 4, 2020 (Filed With SEC on March 18, 2021)
Employment Agreement, by and between the Registrant and Chris Mason, dated September 1, 2018 (Filed With SEC on March 18, 2021)
Underwriting Agreement, dated November 19, 2020, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on November 20, 2020)
Separation Agreement and Release, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated July 16, 2020 (Filed With SEC on August 6, 2020)
First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on June 9, 2020)
Employment Agreement, by and between the Registrant and Deanna Petersen, dated September 1, 2018 (Filed With SEC on March 16, 2020)
Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018 (Filed With SEC on March 16, 2020)
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 16, 2020)
Underwriting Agreement, dated February 12, 2020, between AVROBIO, Inc., and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated July 16, 2019, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein (Filed With SEC on July 17, 2019)
Consulting Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
Employment Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
Employment Agreement, by and between the Registrant and Steven Avruch, dated December 17, 2018 (Filed With SEC on March 25, 2019)
Separation Agreement and Release, dated January 10, 2019, by and between the Company and Nerissa Kreher, M.D (Filed With SEC on January 11, 2019)
Separation Agreement and Release, dated January 8, 2019, by and between the Company and Katina Dorton (Filed With SEC on January 11, 2019)